SRSF7 knockdown promotes apoptosis of colon and lung cancer cells

Fu,Yu; Wang,Yingze

doi:10.3892/ol.2018.8072

SRSF7 knockdown promotes apoptosis of colon and lung cancer cells

Authors:
- Yu Fu
- Yingze Wang
View Affiliations

Affiliations: College of Bioscience and Bioengineering, Hebei University of Science and Technology, Shijiazhuang, Hebei 050018, P.R. China
Published online on: February 16, 2018 https://doi.org/10.3892/ol.2018.8072
Pages: 5545-5552
Copyright: © Fu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Serine/arginine-rich (SR) proteins are a family of important splicing factors, which are involved in multiple aspects of RNA processing, including splicing, mRNA nuclear export, mRNA stability and translation. Previous studies have identified a number of SR proteins that exhibit abnormal expression in various tumor types. In the present study, the expression and function of serine/arginine‑rich splicing factor 7 (SRSF7) were investigated in colon and lung cancer. Using tissue immunohistochemistry, it was observed that SRSF7 was overexpressed in colon and lung cancer tissues. As the role of SRSF7 in cancer remains to be fully elucidated, the expression of SRSF7 was knocked down in the present study by transfecting SRSF7‑specific small interfering RNAs (siRNAs) into the HCT116 colon cancer cell line and A549 lung cancer cell line, which exhibited elevated expression of SRSF7. MTS assays, western blot analysis, flow cytometry and spectrofluorometer analyses were performed to assess the effects of SRSF7 knockdown on the proliferation and apoptosis of cells. The results demonstrated that the expression of SRSF7 was efficiently knocked down by SRSF7 siRNA, and that SRSF7 knockdown inhibited proliferation and enhanced apoptosis of HCT116 and A549 cells. Further experiments involving BEAS‑2B cells stably overexpressing SRSF7, and A549 cells with stable knockdown of SRSF7 revealed that SRSF7 regulated the splicing of the apoptosis regulator Fas. Collectively, these data indicated that SRSF7 is critical for the survival of colon and lung cancer cells, and may be a potential therapeutic target for the treatment of colon and lung cancer.

View Figures

View References

1	Howard JM and Sanford JR: The RNAissance family: SR proteins as multifaceted regulators of gene expression. Wiley Interdiscip Rev RNA. 6:93–110. 2015. View Article : Google Scholar : PubMed/NCBI
2	Manley JL and Krainer AR: A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). Genes Dev. 24:1073–1074. 2010. View Article : Google Scholar : PubMed/NCBI
3	Zhou Z and Fu XD: Regulation of splicing by SR proteins and SR protein-specific kinases. Chromosoma. 122:191–207. 2013. View Article : Google Scholar : PubMed/NCBI
4	Sahebi M, Hanafi MM, van Wijnen AJ, Azizi P, Abiri R, Ashkani S and Taheri S: Towards understanding pre-mRNA splicing mechanisms and the role of SR proteins. Gene. 587:107–119. 2016. View Article : Google Scholar : PubMed/NCBI
5	Twyffels L, Gueydan C and Kruys V: Shuttling SR proteins: More than splicing factors. FEBS J. 278:3246–3255. 2011. View Article : Google Scholar : PubMed/NCBI
6	Anczukow O and Krainer AR: Splicing-factor alterations in cancers. RNA. 22:1285–1301. 2016. View Article : Google Scholar : PubMed/NCBI
7	Shilo A, Siegfried Z and Karni R: The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression. Mol Cell Oncol. 2:e9709552014. View Article : Google Scholar : PubMed/NCBI
8	Das S and Krainer AR: Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer. Mol Cancer Res. 12:1195–1204. 2014. View Article : Google Scholar : PubMed/NCBI
9	Cavaloc Y, Popielarz M, Fuchs JP, Gattoni R and Stevenin J: Characterization and cloning of the human splicing factor 9G8: A novel 35 kDa factor of the serine/arginine protein family. EMBO. 13:2639–2649. 1994.
10	Popielarz M, Cavaloc Y, Mattei MG, Gattoni R and Stevenin J: The gene encoding human splicing factor 9G8. Structure, chromosomal localization, and expression of alternatively processed transcripts. J Biol Chem. 270:17830–17835. 1995. View Article : Google Scholar : PubMed/NCBI
11	Galiana-Arnoux D, Lejeune F, Gesnel MC, Stevenin J, Breathnach R and Del Gatto-Konczak F: The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20. J Biol Chem. 278:32943–32953. 2003. View Article : Google Scholar : PubMed/NCBI
12	ten Dam GB, Zilch CF, Wallace D, Wieringa B, Beverley PC, Poels LG and Screaton GR: Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors. J Immunol. 164:5287–5295. 2000. View Article : Google Scholar : PubMed/NCBI
13	Raponi M, Kralovicova J, Copson E, Divina P, Eccles D, Johnson P, Baralle D and Vorechovsky I: Prediction of single-nucleotide substitutions that result in exon skipping: Identification of a splicing silencer in BRCA1 exon 6. Hum Mutat. 32:436–444. 2011. View Article : Google Scholar : PubMed/NCBI
14	Gao L, Wang J, Wang Y and Andreadis A: SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations. Mol Cell Neurosci. 34:48–58. 2007. View Article : Google Scholar : PubMed/NCBI
15	Huang Y and Steitz JA: Splicing factors SRp20 and 9G8 promote the nucleocytoplasmic export of mRNA. Mol Cell. 7:899–905. 2001. View Article : Google Scholar : PubMed/NCBI
16	Swartz JE, Bor YC, Misawa Y, Rekosh D and Hammarskjold ML: The shuttling SR protein 9G8 plays a role in translation of unspliced mRNA containing a constitutive transport element. J Biol Chem. 282:19844–19853. 2007. View Article : Google Scholar : PubMed/NCBI
17	Hatakeyama S, Sugihara K, Nakayama J, Akama TO, Wong SM, Kawashima H, Zhang J, Smith DF, Ohyama C, Fukuda M and Fukuda MN: Identification of mRNA splicing factors as the endothelial receptor for carbohydrate-dependent lung colonization of cancer cells. Proc Natl Acad Sci USA. 106:pp. 3095–3100. 2009; View Article : Google Scholar : PubMed/NCBI
18	Kim HR, Lee GO, Choi KH, Kim DK, Ryu JS, Hwang KE, Na KJ, Choi C, Kuh JH, Chung MJ, et al: SRSF5: A novel marker for small-cell lung cancer and pleural metastatic cancer. Lung Cancer. 99:57–65. 2016. View Article : Google Scholar : PubMed/NCBI
19	Bouillet P and O'Reilly LA: CD95, BIM and T cell homeostasis. Nat Rev Immunol. 9:514–519. 2009. View Article : Google Scholar : PubMed/NCBI
20	Villa-Morales M and Fernandez-Piqueras J: Targeting the Fas/FasL signaling pathway in cancer therapy. Exp Opin Ther Targets. 16:85–101. 2012. View Article : Google Scholar
21	David CJ and Manley JL: Alternative pre-mRNA splicing regulation in cancer: Pathways and programs unhinged. Genes Dev. 24:2343–2364. 2010. View Article : Google Scholar : PubMed/NCBI
22	Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ and Mountz JD: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1759–1762. 1994. View Article : Google Scholar : PubMed/NCBI
23	Kondera-Anasz Z, Mielczarek-Palacz A and Sikora J: Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors. Apoptosis. 10:1143–1149. 2005. View Article : Google Scholar : PubMed/NCBI
24	Sheen-Chen SM, Chen HS, Eng HL and Chen WJ: Circulating soluble Fas in patients with breast cancer. World J Surg. 27:10–13. 2003. View Article : Google Scholar : PubMed/NCBI
25	Liu JH, Wei S, Lamy T, Li Y, Epling-Burnette PK, Djeu JY and Loughran TP Jr: Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia. Blood. 100:1449–1453. 2002.PubMed/NCBI
26	Tejedor JR, Papasaikas P and Valcarcel J: Genome-wide identification of Fas/CD95 alternative splicing regulators reveals links with iron homeostasis. Mol Cell. 57:23–38. 2015. View Article : Google Scholar : PubMed/NCBI
27	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
28	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
29	Fu Y, Huang B, Shi Z, Han J, Wang Y, Huangfu J and Wu W: SRSF1 and SRSF9 RNA binding proteins promote Wnt signalling-mediated tumorigenesis by enhancing beta-catenin biosynthesis. EMBO Mol Med. 5:737–750. 2013. View Article : Google Scholar : PubMed/NCBI
30	Saijo S, Kuwano Y, Masuda K, Nishikawa T, Rokutan K and Nishida K: Serine/arginine-rich splicing factor 7 regulates p21-dependent growth arrest in colon cancer cells. J Med Invest. 63:219–226. 2016. View Article : Google Scholar : PubMed/NCBI